A M Reznik

1.3k total citations · 1 hit paper
30 papers, 882 citations indexed

About

A M Reznik is a scholar working on Clinical Psychology, Psychiatry and Mental health and Biological Psychiatry. According to data from OpenAlex, A M Reznik has authored 30 papers receiving a total of 882 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Clinical Psychology, 8 papers in Psychiatry and Mental health and 5 papers in Biological Psychiatry. Recurrent topics in A M Reznik's work include Schizophrenia research and treatment (8 papers), Tryptophan and brain disorders (5 papers) and Posttraumatic Stress Disorder Research (4 papers). A M Reznik is often cited by papers focused on Schizophrenia research and treatment (8 papers), Tryptophan and brain disorders (5 papers) and Posttraumatic Stress Disorder Research (4 papers). A M Reznik collaborates with scholars based in Russia, United States and United Kingdom. A M Reznik's co-authors include Ferenc Martényi, Sergey Mosolov, Lu Zhang, Smulevich Ab, Darryle D. Schoepp, Morozova Ma, А С Аведисова, В А Точилов, Kimberley Jackson and Bryan G. Johnson and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Journal of Applied Microbiology.

In The Last Decade

A M Reznik

25 papers receiving 854 citations

Hit Papers

Activation of mGlu2/3 receptors as a new approach to trea... 2007 2026 2013 2019 2007 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
    2007 790 citations Lu Zhang, Ferenc Martényi et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A M Reznik Russia 6 592 422 208 153 146 30 882
L. M. Bardenstein Russia 3 581 1.0× 410 1.0× 265 1.3× 133 0.9× 148 1.0× 6 887
В А Точилов Russia 3 579 1.0× 410 1.0× 237 1.1× 133 0.9× 137 0.9× 6 860
Andreev Bv Russia 7 600 1.0× 416 1.0× 203 1.0× 136 0.9× 146 1.0× 30 876
Ana D. Stan United States 8 404 0.7× 336 0.8× 233 1.1× 132 0.9× 337 2.3× 9 972
Smulevich Ab Russia 11 596 1.0× 428 1.0× 517 2.5× 182 1.2× 153 1.0× 72 1.3k
Geoffrey Pavey Australia 18 563 1.0× 502 1.2× 250 1.2× 133 0.9× 76 0.5× 34 922
Yuko Okahisa Japan 19 280 0.5× 277 0.7× 262 1.3× 111 0.7× 76 0.5× 44 821
Agnès L. Auclair France 18 834 1.4× 483 1.1× 217 1.0× 74 0.5× 148 1.0× 27 1.1k
Taisuke Yoshida Japan 12 234 0.4× 215 0.5× 134 0.6× 162 1.1× 132 0.9× 14 631
Lisa D. Kochan United States 10 589 1.0× 346 0.8× 433 2.1× 124 0.8× 364 2.5× 11 1.1k

Countries citing papers authored by A M Reznik

Since Specialization
Citations

This map shows the geographic impact of A M Reznik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A M Reznik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A M Reznik more than expected).

Fields of papers citing papers by A M Reznik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A M Reznik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A M Reznik. The network helps show where A M Reznik may publish in the future.

Co-authorship network of co-authors of A M Reznik

This figure shows the co-authorship network connecting the top 25 collaborators of A M Reznik. A scholar is included among the top collaborators of A M Reznik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A M Reznik. A M Reznik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zorkina, Yana, Olga Abramova, A M Reznik, et al.. (2025). Serum Cortisol and Interleukin-6 as Key Biomarkers for a Diagnostic Algorithm of Combat-Related PTSD. Brain Sciences. 15(12). 1319–1319.
2.
Sacchi, Cláudio Tavares, Karoline Rodrigues Campos, Simony Trevizan Guerra, et al.. (2025). Detection of multiple clones and extended-spectrum β-lactamase production among Klebsiella pneumoniae complex isolates from the milk of cows with different severity scores of clinical mastitis. Letters in Applied Microbiology. 78(10).
3.
Morozova, Irina, et al.. (2024). Potential Neurophysiological Markers of Combat-Related Post-Traumatic Stress Disorder: A Cross-Sectional Diagnostic Study. SHILAP Revista de lepidopterología. 5(2). 31–44.
4.
5.
6.
7.
Morozova, Аnna, Yana Zorkina, Olga Abramova, et al.. (2021). Associations of Genetic Polymorphisms and Neuroimmune Markers With Some Parameters of Frontal Lobe Dysfunction in Schizophrenia. Frontiers in Psychiatry. 12. 655178–655178. 12 indexed citations
8.
Tkachev, Anna, Elena Stekolshchikova, Аnna Morozova, et al.. (2021). Ceramides: Shared Lipid Biomarkers of Cardiovascular Disease and Schizophrenia. SHILAP Revista de lepidopterología. 2(3). 35–43. 3 indexed citations
9.
Reznik, A M, et al.. (2020). Alimemazine in treatment of agitation in schizophrenia. S S Korsakov Journal of Neurology and Psychiatry. 120(6). 68–68. 4 indexed citations
10.
Латанов, А. В., et al.. (2020). Network analysis of cognitive, oculomotor and speech parameters in schizophrenia. S S Korsakov Journal of Neurology and Psychiatry. 120(6). 54–54. 5 indexed citations
11.
Reznik, A M, et al.. (2020). Psychotic disorders in the veterans of local wars. S S Korsakov Journal of Neurology and Psychiatry. 120(6). 31–31. 2 indexed citations
12.
Ushakova, Valeriya, et al.. (2020). Молекулярно-биологические аспекты депрессивных состояний: современный взгляд на проблему. Молекулярная биология. 54(5). 725–749. 6 indexed citations
13.
Reznik, A M, et al.. (2020). Negative Symptoms of Schizophrenia: New Prospects of Cariprazine Treatment. SHILAP Revista de lepidopterología. 1(2). 43–51. 4 indexed citations
14.
15.
Morozova, Аnna, Yana Zorkina, Pavlov Ka, et al.. (2019). Association of rs4680 COMT, rs6280 DRD3, and rs7322347 5HT2A With Clinical Features of Youth-Onset Schizophrenia. Frontiers in Psychiatry. 10. 830–830. 14 indexed citations
16.
Kostyuk, G. P., et al.. (2019). Perspectives of the use of pharmacogenetic tests in neurology and psychiatry. S S Korsakov Journal of Neurology and Psychiatry. 119(9). 131–131. 4 indexed citations
17.
Ilinsky, Valery, et al.. (2018). Future directions in genome-wide association studies of schizophrenia spectrum disorders. Research Repository Saint Petersburg State University (Saint Petersburg State University). 13(1). 72–82. 1 indexed citations
18.
Morozova, Аnna, Eugene Zubkov, Yana Zorkina, et al.. (2017). Genetic aspects of schizophrenia. S S Korsakov Journal of Neurology and Psychiatry. 117(6). 126–126. 4 indexed citations
19.
Mosolov, Sergey, Smulevich Ab, Н. Г. Незнанов, et al.. (2011). mGlu2/3 Agonists – a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial. Neuroscience and Behavioral Physiology. 41(6). 559–566. 1 indexed citations
20.
Zhang, Lu, Ferenc Martényi, Stephen L. Lowe, et al.. (2007). Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial. Nature Medicine. 13(9). 1102–1107. 790 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. M. Bardenstein Breakdown of academic impact, for papers by В А Точилов Breakdown of academic impact, for papers by Andreev Bv Breakdown of academic impact, for papers by Ana D. Stan Breakdown of academic impact, for papers by Smulevich Ab Breakdown of academic impact, for papers by Geoffrey Pavey Breakdown of academic impact, for papers by Yuko Okahisa Breakdown of academic impact, for papers by Agnès L. Auclair Breakdown of academic impact, for papers by Taisuke Yoshida Breakdown of academic impact, for papers by Lisa D. Kochan
Rankless by CCL
2026